O'Brien Evelyn, Dietrich Daniel R
Environmental Toxicology, University of Konstanz, Konstanz, D-78457, Germany.
Trends Biotechnol. 2004 Jul;22(7):326-30. doi: 10.1016/j.tibtech.2004.05.003.
The strategy of passing much of European Union (EU) waste water through a sewage treatment plant (STP) before discharging it into rivers or lakes has done much to improve the quality of our inland waterways. But we still face a very worrying situation. Environmental problems have surfaced in conjunction with the STPs and their effluent recipients, and attention has turned to human pharmaceuticals and endocrine active substances, in particular, as another source of potential pollutants. Trying to assess the detrimental effects of these chemicals on the aquatic environment represents an extreme cost in terms of animals, time and finance. Instead, it would be better to go back to basics and to prevent entry of these substances into our aquatic environment.
欧盟的许多废水在排入河流或湖泊之前,都要经过污水处理厂处理,这一策略在很大程度上改善了内陆水道的水质。但我们仍面临着非常令人担忧的局面。与污水处理厂及其污水排放受体相关的环境问题已经出现,人们尤其将注意力转向了人类药物和内分泌活性物质,将其视为潜在污染物的另一个来源。试图评估这些化学物质对水生环境的有害影响,在动物、时间和资金方面都要付出巨大代价。相反,最好回归根本,防止这些物质进入我们的水生环境。